{"id":9778,"date":"2025-10-13T06:34:33","date_gmt":"2025-10-13T11:34:33","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=9778"},"modified":"2025-10-13T07:34:38","modified_gmt":"2025-10-13T12:34:38","slug":"nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u30012025\u5e74\u7c73\u56fd\u773c\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u8907\u6570\u767a\u8868\u3092\u767a\u8868"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"9778\" class=\"elementor elementor-9778\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6d5ad04f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6d5ad04f\" data-element_type=\"section\" data-e-type=\"section\">\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5bf9bdef\" data-id=\"5bf9bdef\" data-element_type=\"column\" data-e-type=\"column\">\r\n\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e3a8c93 elementor-widget elementor-widget-text-editor\" data-id=\"e3a8c93\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"legendSpanClass\">\u30c0\u30e9\u30b9<\/span>,\u00a0<span class=\"legendSpanClass\">2025\u5e7410\u670813\u65e5<\/span>\u00a0 \u2014\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>, \u7db2\u819c\u5909\u6027\u306b\u3088\u308b\u5149\u53d7\u5bb9\u4f53\u55aa\u5931\u304a\u3088\u3073\u8996\u899a\u969c\u5bb3\u306e\u60a3\u8005\u5411\u3051\u306b\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u304a\u3088\u3073\u5546\u696d\u5316\u306b\u53d6\u308a\u7d44\u3080\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b \u306f\u672c\u65e5\u3001\u00a0<i>\u30a2\u30e1\u30ea\u30ab\u773c\u79d1\u5b66\u4f1a<\/i>\u00a0<a href=\"https:\/\/www.aao.org\/annual-meeting\">(AAO) 2025\u5e74\u5e74\u6b21\u7dcf\u4f1a<\/a>, 2025\u5e7410\u670818\u65e5\uff5e20\u65e5\u306b\u30d5\u30ed\u30ea\u30c0\u5dde\u30aa\u30fc\u30e9\u30f3\u30c9\u3067\u958b\u50ac\u3055\u308c\u308b\u307b\u304b\u3001\u00a0<i><a href=\"https:\/\/www.eyecelerator.com\/\" target=\"_blank\" rel=\"nofollow noopener\">Eyecelerator@AAO 2025<\/a><\/i><i>,<\/i>\u00a02025\u5e7410\u670816\u65e5\u3001\u540c\u3058\u304f\u30aa\u30fc\u30e9\u30f3\u30c9\u306b\u3066\u3002.<\/p><p>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u304a\u3088\u3073\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u3001\u72ec\u81ea\u306e\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3088\u308b\u8996\u529b\u56de\u5fa9\u6280\u8853\u3092\u5c55\u793a\u3059\u308b\u4e88\u5b9a\u3067\u3059\u3002\u3053\u308c\u3089\u306e\u75be\u60a3\u306f\u3044\u305a\u308c\u3082\u3001\u73fe\u5728\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u6cbb\u7642\u6cd5\u304c\u306a\u3044\u3001\u751f\u6d3b\u306b\u652f\u969c\u3092\u304d\u305f\u3059\u6df1\u523b\u306a\u75c5\u6c17\u3067\u3059\u3002.<\/p><p>\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u8a73\u7d30\uff1a<\/p><p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0<i>\u201c\u300c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u7d39\u4ecb\u300d\uff08Eyecelerator @AAO 2025\uff09<br class=\"dnr\" \/><\/i><b>\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a\u00a0<\/b><i>\u5f8c\u90e8\/\u7db2\u819c<br class=\"dnr\" \/><\/i><b>\u65e5\u4ed8\uff0f\u6642\u9593:<\/b>\u00a02025\u5e7410\u670816\u65e5\uff08\u6728\uff09\u5348\u5f8c1\u664240\u5206\uff5e1\u664245\u5206\uff08\u7c73\u56fd\u6771\u90e8\u590f\u6642\u9593\uff09<br class=\"dnr\" \/><b>\u4f4d\u7f6e\uff1a<\/b>\u00a0W230<br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b><a href=\"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/sam-barone\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30b5\u30df\u30e5\u30a8\u30eb\u30fb\u30d0\u30ed\u30f3\u533b\u5e2b\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005<\/a><\/p><p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0<i>\u201c\u300c\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u5bfe\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u306b\u95a2\u3059\u308bMCO-010 RESTORE\u8a66\u9a13\u306e\u5ef6\u9577\u89e3\u6790\u306b\u3088\u308b152\u9031\u9593\u306e\u6b8b\u5b58\u30c7\u30fc\u30bf\u300d\u201d<br class=\"dnr\" \/><\/i><b>\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a<\/b>\u00a0\u7b2cXI\u7ae0\uff1a\u6700\u65b0\u306e\u52d5\u5411\u3001\u30d1\u30fc\u30c8II<br class=\"dnr\" \/><b>\u65e5\u4ed8\uff0f\u6642\u9593:<\/b>\u00a02025\u5e7410\u670818\u65e5\uff08\u571f\uff09\u5348\u524d8\u664211\u5206\uff5e8\u664218\u5206\uff08\u7c73\u56fd\u6771\u90e8\u590f\u6642\u9593\uff09<br class=\"dnr\" \/><b>\u4f4d\u7f6e\uff1a<\/b>\u00a0W415 \u30d0\u30ec\u30f3\u30b7\u30a2<br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a<\/b>\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/allen-ho-vac\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30a2\u30ec\u30f3\u30fbC\u30fb\u30db\u30fc\u533b\u5e2b\uff08\u533b\u5b66\u535a\u58eb\u3001\u7c73\u56fd\u5916\u79d1\u5c02\u9580\u533b\u3001\u7c73\u56fd\u7db2\u819c\u5916\u79d1\u5c02\u9580\u533b\uff09\u3001\u30a6\u30a3\u30eb\u30ba\u773c\u79d1\u75c5\u9662\u4e3b\u4efb\u5916\u79d1\u533b\u517c\u7db2\u819c\u7814\u7a76\u90e8\u9577\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u6700\u9ad8\u533b\u7642\u9867\u554f<\/a>.<\/p><p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0<i>\u201c\u300c\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u306b\u5bfe\u3059\u308bMCO-010\u5149\u907a\u4f1d\u5b66\u7642\u6cd5\u306b\u3088\u308b\u3001\u8907\u6570\u56de\u306e\u8a55\u4fa1\u306b\u304a\u3051\u308b\u8996\u529b\u6539\u5584\u300d\u201d<br class=\"dnr\" \/><\/i><b>\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a<\/b>\u00a0\u30dd\u30b9\u30bf\u30fc\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff1a\u7db2\u819c\u3001\u785d\u5b50\u4f53<br class=\"dnr\" \/><b>\u65e5\u4ed8\uff0f\u6642\u9593:<\/b>\u00a02025\u5e7410\u670818\u65e5\uff08\u571f\uff09\u5348\u5f8c1\u664245\u5206\uff5e\u5348\u5f8c2\u664215\u5206\uff08\u7c73\u56fd\u6771\u90e8\u590f\u6642\u9593\uff09<br class=\"dnr\" \/><b>\u4f4d\u7f6e\uff1a\u00a0<\/b>\u30db\u30fc\u30ebWB4\u3001\u30b9\u30c6\u30fc\u30b7\u30e7\u30f31<br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a<\/b>\u00a0<a href=\"https:\/\/www.retinaconsultantstexas.com\/retina-specialists\/kenneth-fan-md\" target=\"_blank\" rel=\"nofollow noopener\">\u30b1\u30cd\u30b9\u30fbC\u30fb\u30d5\u30a1\u30f3\u533b\u5e2b\u3001\u30c6\u30ad\u30b5\u30b9\u7db2\u819c\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8<\/a><\/p><p><b>\u30bf\u30a4\u30c8\u30eb<i>:<\/i><\/b>\u00a0<i>\u00a0\u201c\u300c\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u304a\u3088\u3073\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u306e\u6210\u4eba\u60a3\u8005\u306b\u5bfe\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u300d\u201d<br class=\"dnr\" \/><\/i><b>\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a<\/b>\u00a0\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6cbb\u7642\u30a2\u30d7\u30ed\u30fc\u30c1<br class=\"dnr\" \/><b>\u65e5\u4ed8\uff0f\u6642\u9593:<\/b>\u00a02025\u5e7410\u670820\u65e5\uff08\u6708\uff09\u5348\u524d8\u664230\u5206\uff5e8\u664245\u5206\uff08\u7c73\u56fd\u6771\u90e8\u590f\u6642\u9593\uff09<br class=\"dnr\" \/><b>\u4f4d\u7f6e\uff1a<\/b>\u00a0W311E<br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b><a href=\"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/samarendra-mohanty\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/a>; \u305d\u3057\u3066\u00a0<a href=\"https:\/\/doctors.columbia.edu\/us\/ny\/new-york\/stephen-h-tsang-md-phd-622-w-168th-street\" target=\"_blank\" rel=\"nofollow noopener\">\u30b9\u30c6\u30a3\u30fc\u30d6\u30f3\u30fb\u30c4\u30a1\u30f3\u533b\u5e2b\uff08\u533b\u5b66\u535a\u58eb\u3001\u30b3\u30ed\u30f3\u30d3\u30a2\u5927\u5b66\u30a2\u30fc\u30d3\u30f3\u30b0\u533b\u7642\u30bb\u30f3\u30bf\u30fc\uff09<\/a>.<\/p><p>\u201c\u300cAAO\u3068Eyecelerator 2025\u3067\u6700\u65b0\u306eMCO-010\u30c7\u30fc\u30bf\u3092\u5171\u6709\u3057\u3001\u8b70\u8ad6\u3067\u304d\u308b\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u300d\u3068\u8ff0\u3079\u305f\u3002\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/sulagna-bhattcharya\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30b9\u30e9\u30cb\u30e3\u30fb\u30d0\u30bf\u30c1\u30e3\u30ea\u30e4\u3001\u6700\u9ad8\u7d4c\u55b6\u8cac\u4efb\u8005<\/a>. \u300c\u3053\u308c\u3089\u306e\u767a\u8868\u306f\u3001\u5f53\u793e\u306e\u81e8\u5e8a\u304a\u3088\u3073\u898f\u5236\u9762\u3067\u306e\u57fa\u76e4\u304c\u5f15\u304d\u7d9a\u304d\u5f37\u56fa\u3067\u3042\u308b\u3053\u3068\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u306b\u5bfe\u3059\u308b\u751f\u7269\u88fd\u5264\u627f\u8a8d\u7533\u8acb\uff08BLA\uff09\u304c\u73fe\u5728\u9032\u884c\u4e2d\u3067\u3042\u308a\u3001\u6b27\u5dde\u533b\u85ac\u54c1\u5e81\uff08EMA\uff09\u304b\u3089\u65b0\u305f\u306b5\u3064\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u305f\u3053\u3068\u3067\u3001\u5f53\u793e\u306fMCO-010\u3092\u5931\u660e\u306b\u3064\u306a\u304c\u308b\u7db2\u819c\u75be\u60a3\u306e\u60a3\u8005\u3055\u3093\u306b\u5c4a\u3051\u308b\u305f\u3081\u306e\u5f37\u529b\u306a\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u63a8\u9032\u529b\u3092\u751f\u307f\u51fa\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u201c<\/p><p><b>MCO\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>MCO\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\uff08GA\uff09\u306a\u3069\u306e\u5149\u53d7\u5bb9\u4f53\u5909\u6027\u75c7\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u3092\u76ee\u7684\u3068\u3057\u305f\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u5358\u56de\u6295\u4e0e\u306e\u785d\u5b50\u4f53\u5185\u6cbb\u7642\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002MCO\u306f\u3001\u9ad8\u5bc6\u5ea6\u306e\u53cc\u6975\u7db2\u819c\u7d30\u80de\u3092\u6d3b\u6027\u5316\u3057\u3066\u5149\u611f\u53d7\u6027\u3092\u6301\u305f\u305b\u308b\u3053\u3068\u3067\u3001\u5149\u53d7\u5bb9\u4f53\u6b7b\u5f8c\u306b\u6b8b\u5b58\u3059\u308b\u8996\u899a\u56de\u8def\u3092\u6d3b\u7528\u3057\u307e\u3059\u3002MCO\u6cbb\u7642\u306f\u3001\u907a\u4f1d\u5b50\u691c\u67fb\u3001\u4fb5\u8972\u7684\u306a\u624b\u8853\u3001\u307e\u305f\u306f\u7e70\u308a\u8fd4\u3057\u6295\u4e0e\u3092\u5fc5\u8981\u3068\u3057\u306a\u3044\u305f\u3081\u3001\u65e2\u5b58\u306e\u7db2\u819c\u8a3a\u7642\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u5185\u3067\u5e45\u5e83\u3044\u60a3\u8005\u306b\u9069\u7528\u53ef\u80fd\u3067\u3059\u3002.<\/p><p><b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u6570\u767e\u4e07\u4eba\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>\uff09\u3001FDA\u3078\u306eBLA\u7533\u8acb\u304c\u9806\u6b21\u958b\u59cb\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001MCO-010\u306f\u907a\u4f1d\u5b50\u691c\u67fb\u3092\u5fc5\u8981\u3068\u305b\u305a\u3001\u8a3a\u7642\u6240\u30671\u56de\u6ce8\u5c04\u3059\u308b\u3060\u3051\u3067\u6295\u4e0e\u3067\u304d\u308b\u305f\u3081\u3001RP\u60a3\u8005\u306e\u6a19\u6e96\u6cbb\u7642\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/12\/nanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02025\u5e74\u306b\u3001MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3068\u30b9\u30bf\u30d5\u30a3\u30f3\u30fb\u30c7\u30a3\u30d5\u30a3\u30b7\u30eb\uff08SD\uff09\u306e\u4e21\u65b9\u3067FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u304a\u3088\u3073\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3001SD\u3067\u306fRMAT\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u975e\u75c7\u5019\u6027\u304a\u3088\u3073\u75c7\u5019\u6027\u306e\u687f\u4f53\u30fb\u9310\u4f53\u512a\u4f4d\u6027\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3001\u9ec4\u6591\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3092\u5bfe\u8c61\u3068\u3059\u308bEMA\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u5730\u7406\u7684\u840e\u7e2e\uff08GA\uff09\u306b\u304a\u3051\u308bMCO\u306e\u7b2c2\u76f8\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u30012025\u5e74\u672b\u307e\u3067\u306b\u958b\u59cb\u3055\u308c\u308b\u4e88\u5b9a\u3067\u3059\u3002IND\u7533\u8acb\u6e96\u5099\u304c\u6574\u3063\u3066\u3044\u308b\u305d\u306e\u4ed6\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001\u30ec\u30fc\u30d0\u30fc\u5148\u5929\u6027\u9ed2\u5185\u969c\uff08LCA\uff09\u304c\u3042\u308a\u307e\u3059\u3002.<\/p><p><b>\u63a5\u89e6\uff1a<br class=\"dnr\" \/><\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<br class=\"dnr\" \/>(817) 857-1186<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a><\/p><p>\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>DALLAS,\u00a0Oct. 13, 2025\u00a0 \u2014\u00a0Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, today announced multiple presentations at the\u00a0American Academy of Ophthalmology\u00a0(AAO) 2025 Annual Meeting, to be held October 18-20, 2025 in Orlando, FL, as well as at\u00a0Eyecelerator@AAO 2025,\u00a0on October 16, 2025, also in Orlando. Nanoscope will showcase the vision-restoring proprietary Multi-Characteristic Opsin (MCO) platform for patients with severe vision loss from retinitis pigmentosa (RP) and Stargardt disease (SD), both debilitating conditions with no currently approved treatments. Presentation Details: Title:\u00a0\u201cNanoscope Therapeutics Company Showcase\u201d (Eyecelerator @AAO 2025)Session:\u00a0Posterior\/RetinalDate \/ Time:\u00a0Thursday, October 16, 2025 | 1:40-1:45 p.m. [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":8971,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-9778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-13T11:34:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T12:34:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting\",\"datePublished\":\"2025-10-13T11:34:33+00:00\",\"dateModified\":\"2025-10-13T12:34:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/\"},\"wordCount\":605,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/\",\"name\":\"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\",\"datePublished\":\"2025-10-13T11:34:33+00:00\",\"dateModified\":\"2025-10-13T12:34:38+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\",\"width\":1200,\"height\":242},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/10\\\/13\\\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7c73\u56fd\u773c\u79d1\u5b66\u4f1a2025\u5e74\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u8907\u6570\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-10-13T11:34:33+00:00","article_modified_time":"2025-10-13T12:34:38+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting","datePublished":"2025-10-13T11:34:33+00:00","dateModified":"2025-10-13T12:34:38+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/"},"wordCount":605,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/","url":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7c73\u56fd\u773c\u79d1\u5b66\u4f1a2025\u5e74\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u8907\u6570\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","datePublished":"2025-10-13T11:34:33+00:00","dateModified":"2025-10-13T12:34:38+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","width":1200,"height":242},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/10\/13\/nanoscope-therapeutics-announces-multiple-presentations-at-the-american-academy-of-ophthalmology-2025-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/9778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=9778"}],"version-history":[{"count":7,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/9778\/revisions"}],"predecessor-version":[{"id":9786,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/9778\/revisions\/9786"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/8971"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=9778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=9778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=9778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}